Skip to main content
. Author manuscript; available in PMC: 2011 Nov 13.
Published in final edited form as: AIDS. 2009 Aug 24;23(13):1735–1742. doi: 10.1097/QAD.0b013e32832b428f

Table 1.

Baseline characteristics of the sample stratified by diagnostic group (n░=░4989)a.

Characteristic Category Total n (%)
(n░=░4989)
SMI n (%)
(n░=░450)
DD n (%)
(n░=░1235)
None n (%)
(n░=░3304)
Chi-square
test
DF
Age (years) 21.34 4
≤39 2214 (44.4) 181 (40.2) 535 (43.3) 1498 (45.4)
40–49 1961 (39.3) 207 (46.0) 523 (42.3) 1231 (37.3)
≥50 813 (16.3) 62 (13.8) 177 (14.3) 574 (17.4)
Sex 57.18 2
Male 3538 (71.3) 277 (62.1) 804 (65.6) 2457 (74.7)
Female 1421 (28.7) 169 (37.9) 422 (34.4) 830 (25.3)
Race 26.50 4
Black 2100 (42.1) 160 (35.6) 503 (40.7) 1437 (43.5)
Hispanic/other 1593 (31.9) 180 (40.0) 366 (29.6) 1047 (31.7)
White 1295 (26.0) 110 (24.4) 366 (29.6) 819 (24.8)
Nadir CD4
cell count
(cells/μl)
12.32 6
<50 1168 (23.4) 104 (23.1) 253 (20.5) 811 (24.5)
50–200 1562 (31.3) 135 (30.0) 407 (33.0) 1020 (30.9)
201–500 1718 (34.4) 161 (35.8) 453 (36.7) 1104 (33.4)
>500 541 (10.8) 50 (11.1) 122 (9.9) 369 (11.2)
Prior history
of IDU
42.08 2
No 3570 (72.2) 288 (64.3) 824 (67.3) 2458 (75.1)
Yes 1378 (27.8) 160 (35.7) 401 (32.7) 817 (24.9)
No. of MH
visits
1424.13 8
0 3629 (72.7) 123 (27.3) 577 (46.7) 2929 (88.7)
1 444 (8.9) 63 (14.0) 200 (16.2) 181 (5.5)
2–5 587 (11.8) 159 (35.3) 275 (22.3) 153 (4.6)
6–11 191 (3.8) 61 (13.6) 99 (8.0) 31 (0.9)
≥12 138 (2.8) 44 (9.8) 84 (6.8) 10 (0.3)

DD, depressive disorder; DF, degree of freedom; IDU, injection drug use; MH, mental health; SMI, serious mental illness.

a

Sample includes five sites. Patients were observed to go on HAART sometime during the years 2001–2005.

Baseline is the year patient started HAART.

b

Reported P values are from chi-square tests of equal categorical distributions across the three diagnostic groups.